|
Variables
|
Low-CD33(n = 33)
|
High-CD33(n = 53)
|
P
|
|---|
|
Sex(N,M/F)
|
20/13
|
34/19
|
0.742
|
|
Age [Y,M (range)]
|
44 (11–83)
|
47 (16–86)
|
0.457
|
|
WBC[109/L,M (range)]
|
16.30 (0.8–145.2)
|
54.66 (0.9–471.6)
|
0.007
|
|
PLT[109/L,M (range)]
|
58.71 (7.0–309.0)
|
58.70 (3.0–275.0)
|
1.000
|
|
primitive cell (%)
|
46.64 (16.7–81.5)
|
60.60 (7.5–98.8)
|
0.005
|
|
FAB subtype (N,%)
|
0.063
|
|
M0
|
0 (0)
|
1 (1.9)
| |
|
M1
|
0 (0)
|
4 (7.5)
|
|
M2
|
27 (81.8)
|
23 (43.4)
|
|
M4
|
5 (15.2)
|
16 (30.2)
|
|
M5
|
1 (3.0)
|
9 (17.0)
|
|
Karyotype
|
0.027
|
|
Normal
|
10 (30.3)
|
29 (54.7)
| |
|
Other
|
23 (69.7)
|
24 (45.3)
| |
|
Gene
| | |
0.114
|
|
Mutated
|
25 (75.8)
|
47 (88.7)
| |
|
Non-Mutated
|
8 (24.2)
|
6 (11.3)
| |
|
Induction chemotherapy
| | |
0.775
|
|
CR (N,%)
|
17 (51.5)
|
29 (54.7)
| |
|
NR (N,%)
|
16 (48.8)
|
24 (45.3)
| |
|
Relapse or not (N,%)
|
0.783
|
|
Yes
|
15 (45.5)
|
21 (39.6)
| |
|
No
|
18 (54.5)
|
31 (58.5)
| |
|
NA
| |
1 (1.9)
| |
- WBC the count of white blood cell; PLT platelets; CR complete remission; NR not remission; YES referred to relapse; NO referred to not relapse; NA not available
